Both in Pharmaceuticals
ABBVIE vs Merck & Co.
Over the past year ABBV returned +19.3% and MRK returned +89.2%; their daily moves had a correlation of 0.46.
ABBV +19.3% MRK +89.2%Growth of $1, one year, split-adjusted
| Metric | ABBV | MRK |
|---|---|---|
| Price | $266.28 | $148.69 |
| Market cap | $470.55B | $366.84B |
| Today | +0.73% | −0.06% |
| 1 month | +3.1% | −0.6% |
| 6 months | +27.2% | +24.3% |
| Year to date | +16.5% | +41.3% |
| 1 year | +21.8% | +91.6% |
| Revenue growth (YoY) | +10.2% | +5.1% |
| Gross margin | 74.7% | 73.5% |
| Net margin | 21.3% | −8.0% |
| P/E (TTM) | 74.8× | 115.6× |
| Price / sales | 7.3× | 5.5× |
| Net cash | -$64.25B | -$46.77B |
| Dividend yield | 2.60% | 2.29% |
| Volatility (60d) | 21.8% | 33.5% |
| Short % of float | 1.1% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).